Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia — Stella

Home/Aneurysmal Subarachnoid Hemorrhage/Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

View on ClinicalTrials.gov

Recruiting

Back to Aneurysmal Subarachnoid Hemorrhage trials

Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

France

University Hospital Bordeaux, Bordeaux

CHUGA, Grenoble

University Hospital of La Réunion, La Réunion

HCL, Lyon

University Hospital of Toulouse, Toulouse

Key details

Phase

Safety & dosing

Sponsor

University Hospital, Toulouse

Enrollment target

~234 participants

Started

July 2021

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.